NCT00724776 Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients Status COMPLETED Phase PHASE1
NCT00718341 Efficacy, Safety and Tolerability of AFQ056 in Fragile X Patients Status COMPLETED Phase PHASE2
NCT00715468 Prospective, 6 Month, Open Label, Conversion Study From Mycophenolate Mofetil (MMF) to PRMYFORTIC* Status COMPLETED Phase N/A
NCT00712985 Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) Status COMPLETED Phase PHASE3
NCT00710801 Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation Status COMPLETED Phase N/A
NCT00710216 Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B Status WITHDRAWN Phase PHASE4
NCT00709969 Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria Status COMPLETED Phase PHASE3
NCT00706134 Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study Status COMPLETED Phase PHASE3
NCT00705575 Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension Status COMPLETED Phase PHASE3
NCT00704847 Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study) Status TERMINATED Phase PHASE3
NCT00703807 Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers Status COMPLETED Phase PHASE1
NCT00703703 Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00701259 Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn Status COMPLETED Phase PHASE3
NCT00699166 Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Status COMPLETED Phase PHASE2
NCT00697619 To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer Status COMPLETED Phase PHASE2
NCT00694460 Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers Status COMPLETED Phase PHASE2
NCT00691873 Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids Status COMPLETED Phase PHASE4
NCT00687804 A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study Status COMPLETED Phase PHASE3